BioCentury
ARTICLE | Clinical News

Bococizumab: Phase III data

July 18, 2016 7:00 AM UTC

Top-line data from the double-blind, international Phase III SPIRE-HR trial in 711 patients with primary hyperlipidemia or mixed dyslipidemia at high or very high risk of cardiovascular events and who...